HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
adinazolam
structure in first source
Networked:
20
relevant articles (
4
outcomes,
5
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzazepines: 5
Benzodiazepines: 8452
adinazolam: 20
Experts
1.
Belzung, Catherine
: 1 article (02/2003)
2.
Prut, Laetitia
: 1 article (02/2003)
Related Diseases
1.
Panic Disorder (Panic Attack)
08/01/1994 - "
At week 4, panic attacks were completely blocked in 57.1% of adinazolam-treated patients and in 39.2% of the placebo-treated patients (p = 0.009).
"
08/01/1994 - "
Adinazolam sustained-release treatment of panic disorder: a double-blind study.
"
02/01/1994 - "
The exact contributions of adinazolam and NDMAD to response in panic disorder could not be determined, because of the correlation between adinazolam and NDMAD concentrations on multiple dosing.(ABSTRACT TRUNCATED AT 250 WORDS)
"
02/01/1994 - "
Relationship between concentrations of adinazolam and its primary metabolite in plasma and therapeutic/untoward effects in the treatment of panic disorder.
"
05/01/1995 - "
We report the results from a multicenter, double-blind, randomized, fixed-dose study designed to evaluate the relationship between daily dose and efficacy of adinazolam-SR in patients with panic disorder with agoraphobia.
"
2.
Agoraphobia
05/01/1995 - "
We report the results from a multicenter, double-blind, randomized, fixed-dose study designed to evaluate the relationship between daily dose and efficacy of adinazolam-SR in patients with panic disorder with agoraphobia.
"
01/01/1994 - "
Out-patients with panic disorder and agoraphobia completed the Stages of Change (SOC) questionnaire, a measure of readiness to change, before being randomly assigned either sustained release (SR) adinazolam or placebo in a 4 week double-blind trial.
"
05/01/1995 - "
Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
"
08/01/1994 - "
Two hundred six outpatients with panic disorder and agoraphobia were randomly assigned to receive 4 weeks of treatment with placebo or sustained-release adinazolam under double-blind conditions.
"
03/01/1993 - "
Nondepressed patients presenting for treatment of panic disorder with agoraphobia (PDA) were studied before treatment (N = 180) and after 4 weeks of treatment with adinazolam sustained release (N = 89) or placebo (N = 91).
"
3.
Anxiety Disorders (Anxiety Disorder)
10/01/1994 - "
4. The results indicate that adinazolam-SR was clearly superior to placebo for the treatment of patients suffering from Generalized Anxiety Disorder.
"
10/01/1994 - "
A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder.
"
02/28/2003 - "
However, compounds (triazolobenzodiazepines such as adinazolam and alprazolam, selective serotonin reuptake inhibitors) that have a different spectrum of therapeutic efficacy in anxiety disorders such as panic attacks, generalized anxiety disorder or obsessive-compulsive disorder were poorly effective as anxiolytics in the open field test, suggesting that this paradigm may not model features of anxiety disorders.
"
4.
Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
02/28/2003 - "
However, compounds (triazolobenzodiazepines such as adinazolam and alprazolam, selective serotonin reuptake inhibitors) that have a different spectrum of therapeutic efficacy in anxiety disorders such as panic attacks, generalized anxiety disorder or obsessive-compulsive disorder were poorly effective as anxiolytics in the open field test, suggesting that this paradigm may not model features of anxiety disorders.
"
5.
Atrophy
04/29/1999 - "
Finally, the benzodiazepine agonist adinazolam was effective in preventing the stress-induced dendritic atrophy.
"
Related Drugs and Biologics
1.
Tablets
2.
Anti-Anxiety Agents (Anxiolytics)
3.
Benzodiazepines
4.
Alprazolam (Xanax)
5.
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
6.
adinazolam mesylate
7.
mono-N-demethyladinazolam
8.
SR-AT
9.
Imipramine (Janimine)
10.
Diazepam (Valium)